Point-of-care testing for infectious diseases set to rise
05 September, 2016The infectious diseases point-of-care testing (POCT) market is set to rise from $696.1 million in 2015 to just over $1.17 billion by 2022, representing a compound annual growth rate of 7.7%.
Better method of bone regeneration
30 August, 2016Biomedical engineers have used a cheap, commercially produced polymer to assist in bone regeneration, which could result in better therapies for spinal injuries, bone grafts and other orthopaedic surgeries.
New chemical to treat koalas with chlamydia
30 August, 2016Australian scientists have announced a breakthrough in their quest for a new drug to treat koalas suffering from chlamydia.
Cannabis deal completed ahead of human trial
23 August, 2016Australian biotech company Medlab has signed a significant cannabis supply agreement with Aphria, a Canadian-licensed producer of medical marijuana.
Detecting doping with a bacterial enzyme
18 August, 2016ANU researchers are engineering a bacterial enzyme that could help detect many performance-enhancing drugs over longer time frames compared with current anti-doping tests.
MTPConnect and ARCS Australia sign MoU
11 August, 2016MTPConnect and ARCS Australia have signed a memorandum of understanding that will officially recognise ARCS as one of MTPConnect's education affiliates.
Biomedical Translation Fund officially opens
04 August, 2016The federal government's Biomedical Translation Fund has been officially launched by Minister for Health and Aged Care Sussan Ley and Minister for Industry, Innovation and Science Greg Hunt.
Synthetic cannabidiol secured for acne program
29 July, 2016Botanix Pharmaceuticals has secured a supply of synthetic cannabidiol, manufactured at commercial scale by its US-based partner, to be used in the development of a treatment for skin diseases.
Positive preliminary results from wet AMD trial
26 July, 2016Opthea has announced positive data from its ongoing first-in-human clinical trial of OPT-302, a VEGF-C/D 'Trap' therapy for wet age-related macular degeneration.
What do gravitational waves and bone grafting have in common?
19 July, 2016 by Lauren DavisWhat if you could grow a bone in the lab using the power of vibration? It sounds fantastic, but UK researchers have collaborated on a method which could do exactly that.
Sleep disorder start-up debuts on the ASX
19 July, 2016Sleep disorder device manufacturer Oventus Medical has made its debut on the Australian Securities Exchange, raising $12 million from a fully subscribed IPO underwritten by Bell Potter.
AusBiotech CEO Anna Lavelle stepping down
18 July, 2016The CEO of AusBiotech, Dr Anna Lavelle, will hand over leadership of the organisation after more than 11 years of service to the Australian biotechnology industry.
FDA clears PeriCoach to go over the counter
13 July, 2016Analytica has been granted FDA clearance for its PeriCoach medical device, previously available in the US by prescription only, to be sold over the counter.
Drug discovery via an online portal
13 July, 2016The Compounds Australia Structure PoRtal (CASPeR) is a newly released online portal providing access to the data of more than 50,000 different compounds and samples, linking Australian researchers in a way that has not been possible previously.
Orthocell approved for tennis elbow study
12 July, 2016Regenerative medicine company Orthocell has received ethics approval to conduct a study comparing surgery for severe tennis elbow to the company's minimally invasive cell therapy Ortho-ATI injection.
